Literature DB >> 30155590

Guest editorial: chronic myeloid leukemia.

Yosuke Minami1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30155590     DOI： 10.1007/s12185-018-2521-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  14 in total

Review 1.  Evolution of the cancer stem cell model.

Authors:  Antonija Kreso; John E Dick
Journal:  Cell Stem Cell       Date:  2014-03-06       Impact factor: 24.633

2.  Deeper molecular response is a predictive factor for treatment-free remission after imatinib discontinuation in patients with chronic phase chronic myeloid leukemia: the JALSG-STIM213 study.

Authors:  Naoto Takahashi; Tetsuzo Tauchi; Kunio Kitamura; Koichi Miyamura; Yoshio Saburi; Yoshihiro Hatta; Yasuhiko Miyata; Shinichi Kobayashi; Kensuke Usuki; Itaru Matsumura; Yosuke Minami; Noriko Usui; Tetsuya Fukuda; Satoru Takada; Maho Ishikawa; Katsumichi Fujimaki; Hiroshi Gomyo; Osamu Sasaki; Kohshi Ohishi; Takaaki Miyake; Kiyotoshi Imai; Hitoshi Suzushima; Hideki Mitsui; Kazuto Togitani; Toru Kiguchi; Yoshiko Atsuta; Shigeki Ohtake; Kazunori Ohnishi; Yukio Kobayashi; Hitoshi Kiyoi; Yasushi Miyazaki; Tomoki Naoe
Journal:  Int J Hematol       Date:  2017-09-19       Impact factor: 2.490

3.  Stem cell gene expression programs influence clinical outcome in human leukemia.

Authors:  Kolja Eppert; Katsuto Takenaka; Eric R Lechman; Levi Waldron; Björn Nilsson; Peter van Galen; Klaus H Metzeler; Armando Poeppl; Vicki Ling; Joseph Beyene; Angelo J Canty; Jayne S Danska; Stefan K Bohlander; Christian Buske; Mark D Minden; Todd R Golub; Igor Jurisica; Benjamin L Ebert; John E Dick
Journal:  Nat Med       Date:  2011-08-28       Impact factor: 53.440

4.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Authors:  T Lapidot; C Sirard; J Vormoor; B Murdoch; T Hoang; J Caceres-Cortes; M Minden; B Paterson; M A Caligiuri; J E Dick
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

5.  Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists.

Authors:  Stéphane Prost; Francis Relouzat; Marc Spentchian; Yasmine Ouzegdouh; Joseph Saliba; Gérald Massonnet; Jean-Paul Beressi; Els Verhoeyen; Victoria Raggueneau; Benjamin Maneglier; Sylvie Castaigne; Christine Chomienne; Stany Chrétien; Philippe Rousselot; Philippe Leboulch
Journal:  Nature       Date:  2015-09-02       Impact factor: 49.962

6.  Heterogeneity in cancer: cancer stem cells versus clonal evolution.

Authors:  Mark Shackleton; Elsa Quintana; Eric R Fearon; Sean J Morrison
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

Review 7.  Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors.

Authors:  Ami B Patel; Thomas O'Hare; Michael W Deininger
Journal:  Hematol Oncol Clin North Am       Date:  2017-08       Impact factor: 3.722

Review 8.  Chronic myeloid leukemia stem cells and molecular target therapies for overcoming resistance and disease persistence.

Authors:  Ai Inoue; Chiharu I Kobayashi; Haruka Shinohara; Kenichi Miyamoto; Nobuhiko Yamauchi; Junichiro Yuda; Yukihiro Akao; Yosuke Minami
Journal:  Int J Hematol       Date:  2018-08-28       Impact factor: 2.490

9.  The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1.

Authors:  Andrew A Wylie; Joseph Schoepfer; Wolfgang Jahnke; Sandra W Cowan-Jacob; Alice Loo; Pascal Furet; Andreas L Marzinzik; Xavier Pelle; Jerry Donovan; Wenjing Zhu; Silvia Buonamici; A Quamrul Hassan; Franco Lombardo; Varsha Iyer; Michael Palmer; Giuliano Berellini; Stephanie Dodd; Sanjeev Thohan; Hans Bitter; Susan Branford; David M Ross; Timothy P Hughes; Lilli Petruzzelli; K Gary Vanasse; Markus Warmuth; Francesco Hofmann; Nicholas J Keen; William R Sellers
Journal:  Nature       Date:  2017-03-22       Impact factor: 49.962

Review 10.  Human hemato-lymphoid system mice: current use and future potential for medicine.

Authors:  Richard A Flavell; Markus G Manz; Anthony Rongvaux; Hitoshi Takizawa; Till Strowig; Tim Willinger; Elizabeth E Eynon
Journal:  Annu Rev Immunol       Date:  2013-01-16       Impact factor: 28.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.